In March 2025, Celgene announced a study is to compare the effectiveness and safety of golcadomide in combination with ...

A couple of months after Thousand Oaks-based Atara Biotherapeutics announced it would be laying off roughly 80 employees, the company confirmed nearly half of those jobs are coming from its Ventura ...

Story March 4 - Atara Biotherapeutics: While the biotech navigates the fallout from the FDA’s move to halt trials of its allogeneic T-cell immunotherapy Ebvallo and a CAR-T candidate ...

which has since been followed by the purchase of gene therapy specialist Asklepios Biopharmaceutical in 2020 and a bolt-on deal with Atara Biotherapeutics for mesothelin-targeted CAR-T cell ...

This is the new 2012 Toyota Camry Atara SX. It’s not technically ... This might be due to the car only having done 2000km. They aren’t the largest chairs you’ll find in a family sedan ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

BioNTech has passed on Autolus Therapeutics’ dual targeting CAR-T cell therapy. One year after securing a chance to ...

Treatment of B-cell Acute Lymphoblastic Leukaemia has been greatly improved by CAR-T therapies, but relapse is still very common. An international team has now found in animal models a new approach ...

Currently, 13 CAR-T treatments have received regulatory approval. Blood cancers have dominated the development pipeline of ...

Incoming CEO Ivan Espinosa isn't shy about his thoughts on icons like the Z and GT-R.